Drugs / DA-8031
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01104948 | May 2010 → Oct 2011 | premature ejaculation | Dong-A Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01798667 | Jan → Apr 2013 | premature ejaculation | Dong-A Pharmaceutical Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DA-8031 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01104948 ↗ |
| Modality | Small molecule | — CHEMBL5095175 ↗ |
| Route | Oral | “After Oral Administration” NCT01104948 ↗ |